No Data
OncoLis Bio, Modaris, and others.
<4588> OncoReBio's 20th subscription rights (with exercise price adjustment clause and exercise suspension clause) issued 0.46 million shares of exercised stocks since the beginning of the month. <4883> Modaris' 12th subscription rights (with exercise price adjustment clause) completed the exercise and issued 2.227 million shares of exercised stocks since the beginning of the month. <9338> INFORIZCH established overseas subsidiaries in the United Kingdom. <9553> MicroAd transferred stocks with changes to its consolidated subsidiary (MADS). <4424> Amaizia with My Medical
Information Strategy and Technology: Interim Report - 16th Period (January 1, 2024 - December 31, 2024)
Information Strategy and Technology: Financial Results Summary for the Second Quarter (Interim Period) of December 2024.
Information Strategy and Technology: FY December 2024 Q2 (interim period) financial results announcement [Japan GAAP] (non-consolidated)
Stocks that hit the daily limit up or down in the morning session.
■Stop Limit■Stop Loss Information on Global Strategy Technology＜1711＞SDS Holdings＜1730＞Asou Foamcrete＜1789＞ETS Holdings＜186A＞Astroscale Holdings＜206A＞PRISM BioLab＜2195＞Amita Holdings＜2375＞Gig Works＜2970＞Good Life Company＜3041＞Viewcathan Holdings＜3110＞Nichimen Corporation＜3133
Volume change rate ranking (13:00) - Libertad, Mitsui Matsushima, etc. ranked in.
*In the volume change rate ranking, you can understand the interest of market participants, such as search trends, by comparing the average volume of the previous 5 days with the volume on the day of delivery. *Top volume change rates [as of July 9th 13:32] (compared to the average volume of the previous 5 days) Code ⇒ Name ⇒ Volume ⇒ 5-day average volume ⇒ volume change rate ⇒ stock price change rate ＜4599＞ Stem Inc. 2024800 62113.32 310.80% 0.076% ＜4825＞ WNI
No Data
